StockOrNot
Open the deck

MetLife (MET)

Financials · $64.1B market cap · SEC CIK 0001099219

$102.44 ▲+0.76% on the day close of Nov 10, 2026
32 Screens poorly
ahead of 32% of the S&P 500 · #60 of 76 in Financials

Next reports on Feb 2, 2027, after the close, with analysts expecting $2.64 in earnings per share.

52-week range $67.33 to $106.72. 4% below its 52-week high and 52% above its low.

The case for MET

The case against

What the score is made of

Each factor is half a curve over reported figures and half a rank among the other Financials companies (momentum is judged against fixed thresholds only), and the five are blended by weight. The score is where that blend places it in the S&P 500. It describes the last filing and the current price. It is not a forecast.

Valuewhat you pay for the earnings and cash, against the growth you get52
Growthhow fast revenue and earnings are moving, this year and over five31
Profitabilityhow much of the revenue becomes profit, and how much of that is cash34
Momentumhow the price has behaved lately77
Stabilityhow violently it moves, what it owes and what it pays you69

The financials

Revenue growth

Is the business growing? Yes

Last 12 months+14.5%
Over 5 years+2.6% a year
FY2025 revenue$77.1B (+9%)

Free cash flow

Is it generating real cash? Not meaningful for a financial company

Profit margins

Is profitability improving? Holding steady

Gross marginn/a
Operating margin9%
Net margin, FY24 → FY25 → now6.2% → 4.4% → 6.2%

Debt vs. cash

Is the balance sheet healthy? Not judged for a financial company

Cash$22.0B
Long-term debtn/a
Net cashn/a

Valuation

Is the stock price reasonable? Yes, about fair

P/E12.5×
Fair P/E for its growth20×
Price / book2.69×
Fair P/B for its ROE1.9×
Forward P/E9.1×
EV / EBITDA8.4×

At 12.5× earnings it trades below the 20× that 5% a year of growth plus a 3.3% dividend would justify. At 2.69× book it trades above the 1.9× that its 19% return on equity would justify; for a financial company that counts for more than earnings.

The financials, five years deep

Pulled from MetLife's XBRL filings on SEC EDGAR. Italic rows are worked out from the others.

FY2025FY2024FY2023FY2022FY2021
Revenue growth
Revenue$77.1B$71.0B$66.9B$68.8B$68.7B
Change on the year+9%+6%−3%0%—
Profit margins
Operating margin8.0%8.4%8.6%8.7%—
Net margin4.4%6.2%2.4%7.7%10.0%
Debt vs. cash
Cash$22.0B$20.1B$20.6B$20.2B$20.0B

What MetLife says it does

Index to Business Page Business Overview & Strategy 5 Segments and Corporate & Other 6 Policyholder Liabilities 10 Underwriting and Pricing 11 Reinsurance Activity 12 Regulation 12 Competition 23 Human Capital Resources 24 Information About Our Executive Officers 25 Trademarks 26 Available Information 26 4 Table of Contents Business Overview & Strategy As used in this Form 10-K, “MetLife,” the “Company,” “we,” “our” and “us” refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates. MetLife is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management. We hold leading market positions in the United States (“U.S.”), Asia, Latin America, Europe and the Middle East. We are also one of the largest institutional investors in the U.S. with a general account portfolio invested primarily in fixed income securities (corporate,…

Risk factors MET lists in its 10-K

Filings

Open MET in the deck

Other Financials companies

BRK.BBerkshire HathawayJPMJPMorgan ChaseVVisaMAMastercardBACBank of AmericaMSMorgan StanleyGSGoldman SachsWFCWells FargoAXPAmerican ExpressCCitigroupBLKBlackRockSCHWCharles Schwab